Literature DB >> 24149819

Should people at low risk of cardiovascular disease take a statin?

John D Abramson1, Harriet G Rosenberg, Nicholas Jewell, James M Wright.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24149819     DOI: 10.1136/bmj.f6123

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  65 in total

1.  Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia.

Authors:  Katie Qi; Emily Reeve; Sarah N Hilmer; Sallie-Anne Pearson; Slade Matthews; Danijela Gnjidic
Journal:  Int J Clin Pharm       Date:  2015-06-06

Review 2.  Big Data and Health Economics: Strengths, Weaknesses, Opportunities and Threats.

Authors:  Brendan Collins
Journal:  Pharmacoeconomics       Date:  2016-02       Impact factor: 4.981

3.  Challenges and opportunities in accessing trial data: an example from statin primary prevention trials.

Authors:  Genevieve Umeh; Mark D Huffman
Journal:  Heart Asia       Date:  2017-04-13

4.  Statin-prescribing trends for primary and secondary prevention of cardiovascular disease.

Authors:  Felicity Brown; Alexander Singer; Alan Katz; Gerald Konrad
Journal:  Can Fam Physician       Date:  2017-11-14       Impact factor: 3.275

Review 5.  Drug development: how academia, industry and authorities interact.

Authors:  Silvio Garattini; Norberto Perico
Journal:  Nat Rev Nephrol       Date:  2014-08-05       Impact factor: 28.314

6.  A chasm of misunderstanding: The widening gap between public perception and scientific consensus.

Authors:  Philip Hunter
Journal:  EMBO Rep       Date:  2014-06-16       Impact factor: 8.807

7.  The effect of statins on muscle symptoms in primary care: the StatinWISE series of 200 N-of-1 RCTs.

Authors:  Emily Herrett; Elizabeth Williamson; Kieran Brack; Alexander Perkins; Andrew Thayne; Haleema Shakur-Still; Ian Roberts; Danielle Prowse; Danielle Beaumont; Zahra Jamal; Ben Goldacre; Tjeerd van Staa; Thomas M MacDonald; Jane Armitage; Michael Moore; Maurice Hoffman; Liam Smeeth
Journal:  Health Technol Assess       Date:  2021-03       Impact factor: 4.014

8.  Cholesterol trials and mortality.

Authors:  John B Warren; Simon B Dimmitt; Hans G Stampfer
Journal:  Br J Clin Pharmacol       Date:  2016-05-02       Impact factor: 4.335

9.  Statin initiations and QRISK2 scoring in UK general practice: a THIN database study.

Authors:  Samuel Finnikin; Ronan Ryan; Tom Marshall
Journal:  Br J Gen Pract       Date:  2017-10-23       Impact factor: 5.386

Review 10.  Cholesterol confusion and statin controversy.

Authors:  Robert DuBroff; Michel de Lorgeril
Journal:  World J Cardiol       Date:  2015-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.